Health-tech company Bioniq raised $ 7.8 million. The lead investor was the Luxembourg-based venture fund OKS Group, which specializes in early stage investments. So, the startup closed round A with a total amount of $ 15 million, a representative of the startup told Rusbase.
Medtech-company Bioniq closed the round of investments for $ 15 million
Ekaterina Kochkina
The funds received will be used to develop the product and expand its presence in the US and Middle East markets.
The second part of the round A investment earlier in Bioniq was invested by Medsi Group.
Bioniq offers a data-driven approach to disease prevention and health promotion. To do this, the company has created a digital platform that aggregates and analyzes data from blood tests, genetic tests and microbiota tests using AI over time.
Based on the analysis results obtained, the system offers an integrated approach to health management:
- recommends which doctors to contact,
- creates personalized vitamin complexes,
- offers an individual program of nutrition, training,
- gives recommendations for lifestyle correction.
It is noted that Bioniq’s work is based on an evidence-based approach.
“We will use the funds raised in this round to provide our customers with even more information about the state of the body using the DNA tests we have developed, as well as to supplement the product line with personalized menus and tools to maintain psychological health,” says Vadim Fedotov, founder of Bioniq.
The service works by subscription and offers two tariffs in Russia, costing from 6990 rubles.
At the moment, the startup has successfully completed pilot projects in Dubai and New York. The company also said that Bioniq has partnered with several wellness centers in Europe, including the Austrian resort Lanserhof. In Russia, the company is developing at the federal level thanks to its partnership with the Medsi network of private clinics.
Bioniq was created in early 2019 by Vadim Fedotov and Konstantin Karuzin. The company is headquartered in London.
In Russia, the development of the company began in July 2019. In February 2020, Bioniq and Medsi launched digital platform for health monitoring.
*The article has been translated based on the content of Rusbase by rb.ru. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!
